Cargando…

Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector species

V920, rVSVΔG-ZEBOV-GP, is a recombinant vesicular stomatitis-Zaire ebolavirus vaccine which has shown an acceptable safety profile and provides a protective immune response against Ebola virus disease (EVD) induced by Zaire ebolavirus in humans. The purpose of this study was to determine whether the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergren, Nicholas A., Miller, Megan R., Monath, Thomas P., Kading, Rebekah C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893201/ https://www.ncbi.nlm.nih.gov/pubmed/29206076 http://dx.doi.org/10.1080/21645515.2017.1412898

Ejemplares similares

rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment
por: Monath, Thomas P., et al.
Publicado: (2019)

Local Mutational Pressures in Genomes of Zaire Ebolavirus and Marburg Virus
por: Khrustalev, Vladislav Victorovich, et al.
Publicado: (2015)

Immunopathogenesis of Severe Acute Respiratory Disease in Zaire ebolavirus-Infected Pigs
por: Nfon, Charles K., et al.
Publicado: (2013)

Bats as putative Zaire ebolavirus reservoir hosts and their habitat suitability in Africa
por: Koch, Lisa K., et al.
Publicado: (2020)

Accounting for population structure reveals ambiguity in the Zaire Ebolavirus reservoir dynamics
por: Vrancken, Bram, et al.
Publicado: (2020)

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus
por: Wolfe, Daniel N., et al.
Publicado: (2020)

Development of an antigen detection assay for early point-of-care diagnosis of Zaire ebolavirus
por: DeMers, Haley L., et al.
Publicado: (2020)

Effect of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo
por: Rupani, Neil, et al.
Publicado: (2022)

Comparison of the Aerosol Stability of 2 Strains of Zaire ebolavirus From the 1976 and 2013 Outbreaks
por: Fischer, Robert J., et al.
Publicado: (2016)

Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2
por: Kang, Yuan-Lin, et al.
Publicado: (2020)

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
por: Clarke, David K., et al.
Publicado: (2006)

dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35
por: Zinzula, Luca, et al.
Publicado: (2012)

High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon
por: Becquart, Pierre, et al.
Publicado: (2010)

Survey and Visual Detection of Zaire ebolavirus in Clinical Samples Targeting the Nucleoprotein Gene in Sierra Leone
por: Li, Huan, et al.
Publicado: (2015)

Host Adaptation and Evolutionary Analysis of Zaire ebolavirus: Insights From Codon Usage Based Investigations
por: Luo, Wen, et al.
Publicado: (2020)

Expression of microRNA in human retinal pigment epithelial cells following infection with Zaire ebolavirus
por: Oliver, Genevieve F., et al.
Publicado: (2019)

The Ecological Significance and Implications of Transovarial Transmission among the Vector-Borne Bunyaviruses: A Review
por: Bergren, Nicholas A., et al.
Publicado: (2018)

Correction: High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon
por: Becquart, Pierre, et al.
Publicado: (2010)

Corrigendum: Survey and Visual Detection of Zaire Ebolavirus in Clinical Samples Targeting the Nucleoprotein Gene in Sierra Leone
por: Li, Huan, et al.
Publicado: (2016)

High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission
por: Morozov, Igor, et al.
Publicado: (2021)

Effect of Gamma Irradiation on the Antibody Response Measured in Human Serum from Subjects Vaccinated with Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine
por: Grant-Klein, Rebecca J., et al.
Publicado: (2019)

Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates
por: Johnson, J. Erik, et al.
Publicado: (2007)

Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
por: Fathi, Anahita, et al.
Publicado: (2019)

Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP Zaire ebolavirus Vaccine to Inform Marburg Virus and Sudan ebolavirus Vaccines
por: Coller, Beth-Ann G., et al.
Publicado: (2022)

Vesicular Stomatitis Virus Transmission: A Comparison of Incriminated Vectors
por: Rozo-Lopez, Paula, et al.
Publicado: (2018)

Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
por: Liu, Guodong, et al.
Publicado: (2021)

Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease
por: Monath, Thomas P., et al.
Publicado: (2023)

Modernizing the Toolkit for Arthropod Bloodmeal Identification
por: Borland, Erin M., et al.
Publicado: (2021)

SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector
por: Kapadia, Sagar U., et al.
Publicado: (2008)

Different Effect of Proteasome Inhibition on Vesicular Stomatitis Virus and Poliovirus Replication
por: Neznanov, Nickolay, et al.
Publicado: (2008)

Phase Transitions Drive the Formation of Vesicular Stomatitis Virus Replication Compartments
por: Heinrich, Bianca S., et al.
Publicado: (2018)

Quantification of Viral and Host Biomarkers in the Liver of Rhesus Macaques: A Longitudinal Study of Zaire Ebolavirus Strain Kikwit (EBOV/Kik)
por: Greenberg, Alexandra, et al.
Publicado: (2020)

Development and Evaluation of a Duo Zaire ebolavirus Real-Time RT-PCR Assay Targeting Two Regions within the Genome
por: Thirion, Laurence, et al.
Publicado: (2019)

Dendritic Cells Generated From Mops condylurus, a Likely Filovirus Reservoir Host, Are Susceptible to and Activated by Zaire Ebolavirus Infection
por: Edenborough, Kathryn M., et al.
Publicado: (2019)

Zaire ebolavirus surveillance near the Bikoro region of the Democratic Republic of the Congo during the 2018 outbreak reveals presence of seropositive bats
por: Seifert, Stephanie N., et al.
Publicado: (2022)

Maternal Immunization Using a Protein Subunit Vaccine Mediates Passive Immunity against Zaire ebolavirus in a Murine Model
por: Williams, Caitlin A., et al.
Publicado: (2022)

Aphthæ, or Vesicular Stomatitis of the Horse
por: Hutcheon, D.
Publicado: (1898)

Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis
por: Case, James Brett, et al.
Publicado: (2020)

Cellular microRNAs Repress Vesicular Stomatitis Virus but Not Theiler’s Virus Replication
por: De Cock, Aurélie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a4qopk1mp0e0nmh477sel2otj9